Caris Life Sciences, Inc.'s total assets for Q2 2025 were $955.06M, an increase of 227.54% from the previous quarter. CAI total liabilities were $502.15M for the fiscal quarter, a -82.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.